EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

MYC-mediated resistance to trametinib and HCQ in PDAC is overcome by CDK4/6 and lysosomal inhibition

Mark R Silvis iD, Dilru Silva iD, Riley Rohweder iD, Sophia Schuman iD, Swapna Gudipaty iD, Amanda Truong iD, Jeffrey Yap iD, Kajsa Affolter iD, Martin McMahon iD, Conan Kinsey iD

Journal of Experimental Medicine · 2023

DOI: 10.1084/jem.20221524 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Experimental Medicine, 2023. Verfasst von Mark R Silvis und 9 weiteren Autor:innen. Beteiligte Einrichtung: Huntsman Cancer Institute, University of Utah , Salt Lake City, UT, USA. Hauptthemen laut MEDLINE: Carcinoma, Pancreatic Ductal, Pancreatic Neoplasms. Die Arbeit wurde bisher 33-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, University of Utah, National Cancer Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pharmacological inhibition of KRAS>RAF>MEK1/2>ERK1/2 signaling has provided no clinical benefit to patients with pancreatic ductal adenocarcinoma (PDAC). Interestingly, combined inhibition of MEK1/2 (with trametinib [T]) plus autophagy (with chloroquine [CQ] or hydroxychloroquine [HCQ]) demonstrated striking anti-tumor effects in preclinical models and in a patient (Patient 1). However, not all patients respond to the T/HCQ regimen, and Patient 1 eventually developed resistant disease. Here we report that primary or acquired resistance is associated with focal DNA copy number gains encompassing c-MYC. Furthermore, ectopic expression of c-MYC in PDAC cell lines rendered them T/HCQ resistant. Interestingly, a CDK4/6 inhibitor, palbociclib (P), also induced autophagy and overrode c-MYC–mediated T/HCQ resistance, such that P/HCQ promoted regression of T/HCQ-resistant PDAC tumors with elevated c-MYC expression. Finally, P/HCQ treatment of Patient 1 resulted in a biochemical disease response. These data suggest that elevated c-MYC expression is both a marker and a mediator of T/HCQ resistance, which may be overcome by the use of P/HCQ.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Pancreatic DuctalPancreatic NeoplasmsHumansChloroquineCyclin-Dependent Kinase 4HydroxychloroquineLysosomesPyridonesPyrimidinonesCyclin-Dependent Kinase 6

Substanzen

ChloroquineCyclin-Dependent Kinase 4HydroxychloroquineCDK4 protein, humantrametinibPyridonesPyrimidinonesCDK6 protein, humanCyclin-Dependent Kinase 6

Autor:innen und Institutionen

  • Huntsman Cancer Institute, University of Utah , Salt Lake City, UT, USA.
  • Department of Oncological Sciences, University of Utah , Salt Lake City, UT, USA.
  • ARUP Laboratories , Salt Lake City, UT, USA.
  • Intermountain Medical Center , Murray, UT, USA.
  • Department of Radiology, University of Utah , Salt Lake City, UT, USA.
  • Department of Pathology, University of Utah , Salt Lake City, UT, USA.

ORCID-Profile: Mark R Silvis, Dilru Silva, Riley Rohweder, Sophia Schuman, Swapna Gudipaty, Amanda Truong, Jeffrey Yap, Kajsa Affolter, Martin McMahon, Conan Kinsey

Förderung

  • NCI NIH HHS
  • University of Utah
  • National Cancer Institute
  • HCI Preclinical Research Shared Resource
  • Lustgarten Foundation
  • Huntsman Cancer Foundation
  • Huntsman GI Disease Center
  • Pfizer Consumer Healthcare

Zitieren

APA

Silvis, M. R., Silva, D., Rohweder, R., Schuman, S., Gudipaty, S., Truong, A., Yap, J., Affolter, K., McMahon, M., & Kinsey, C. (2023). MYC-mediated resistance to trametinib and HCQ in PDAC is overcome by CDK4/6 and lysosomal inhibition. Journal of Experimental Medicine. https://doi.org/10.1084/jem.20221524

Vancouver

Silvis MR, Silva D, Rohweder R, Schuman S, Gudipaty S, Truong A, et al. MYC-mediated resistance to trametinib and HCQ in PDAC is overcome by CDK4/6 and lysosomal inhibition. Journal of Experimental Medicine. 2023. doi:10.1084/jem.20221524

BibTeX
@article{Silvis2023,
  author = {Silvis, Mark R and Silva, Dilru and Rohweder, Riley and Schuman, Sophia and Gudipaty, Swapna and Truong, Amanda and Yap, Jeffrey and Affolter, Kajsa and McMahon, Martin and Kinsey, Conan},
  title = {MYC-mediated resistance to trametinib and HCQ in PDAC is overcome by CDK4/6 and lysosomal inhibition},
  journal = {Journal of Experimental Medicine},
  year = {2023},
  doi = {10.1084/jem.20221524}
}
Kostenlos starten →